Clinical Trial Update: Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update comparing Nexium (esomeprazole) versus Secretol for healing and symptom control in GERD patients with erosive esophagitis, across Phase 1 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Esophagitis Erosive
• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)
• Secretol

Snippet

Sponsor: Effexus Pharmaceutical | Conditions: Gastroesophageal Reflux Disease (GERD), Heartburn | Phase 1, Phase 2 | Status: UNKNOWN